Mycoverse Secures €2.4M to Revolutionize Crop Protection with Fungal-Based Solutions, Reducing Chemical Pesticide Use by Up to 70%

Mycoverse, a pioneering Danish AgTech firm, has successfully raised €2.4 million in pre-Seed equity funding to develop its groundbreaking fungal-based biological alternatives to chemical pesticides. This significant investment, led by Future Food Fund and High-Tech Gründerfonds (HTGF), with participation from PINC, the venture arm of Paulig, marks a crucial step forward in the company's mission to transform the crop protection landscape.



The funding will be utilized to expand Mycoverse's field trials program, bringing the company closer to delivering reliable and effective biological crop protection products that farmers can seamlessly integrate into their existing practices. Founded in 2024 as a spin-out from the Technical University of Denmark (DTU), Mycoverse leverages its AI-driven discovery platform to identify promising fungal strains and develop bioactives that provide superior crop protection.



This innovative approach, combined with Mycoverse's advanced fungal production technology, enables the development of scalable biological crop protection solutions. The company's platform is designed to support solutions across multiple crops, with an initial focus on potato late blight and future applications including grapevine. The crop protection landscape in Europe is evolving rapidly in response to regulatory developments and growing demand for more sustainable agricultural practices.



For everyday users, this could mean accessing produce that is not only healthier but also more sustainably produced. From an industry perspective, the shift towards biological crop protection methods could reshape how farmers manage disease pressures, reducing their reliance on chemical pesticides. The implications extend beyond the agricultural sector, as the adoption of more sustainable practices contributes to a broader environmental impact.



With the European crop protection market undergoing significant changes, Mycoverse is well-positioned to capitalize on the growing demand for innovative, bio-based solutions. The company's ability to rapidly develop high-performing biological candidates, as demonstrated by its swift development of potato blight candidates in just five months, underscores the strength and efficiency of its platform.



As regulatory agencies and the agribusiness sector across Europe accelerate the adoption of biological crop protection methods, Mycoverse aims to expand its platform to additional crops. This strategic move could potentially open up new market opportunities, further solidifying the company's position as a leader in the development of fungal-based biological alternatives to chemical pesticides.



The funding enables Mycoverse to embark on two years of field trials toward commercial validation, a critical step in bringing its solutions to market. With its total fundraising now standing at €4.3 million, Mycoverse is poised to make a significant impact in the agricultural sector, offering farmers reliable, cost-effective, and sustainable solutions to manage persistent disease pressures.



In conclusion, Mycoverse's successful fundraising marks a significant milestone in the company's journey to revolutionize the crop protection landscape. As the agricultural sector continues to evolve, the demand for innovative, bio-based solutions will only continue to grow, and Mycoverse is well-positioned to capitalize on this trend.